Last Updated: 19 Sep 2024
Executive Summary
Encompass Health Corp (EHC) is a leading provider of post-acute healthcare services in the United States. The company has a strong financial position with a market capitalization of $9.3 billion, EBITDA of $1.07 billion, and a trailing PE ratio of 22.88. Encompass Health is expected to continue to grow in the future, with analysts forecasting a target price of $100.91.
Company Overview
Encompass Health Corp is headquartered in Birmingham, Alabama and provides a range of post-acute healthcare services, including inpatient rehabilitation, skilled nursing, home health, and hospice care. The company operates over 130 hospitals and 250 home health and hospice locations in 42 states.
Fundamental Analysis
Encompass Health Corp has a strong financial position. The company's revenue has grown steadily in recent years, reaching $5.07 billion in the trailing twelve months. The company's gross profit margin is 34.6%, and its operating margin is 16.6%. Encompass Health has a strong balance sheet with $1.2 billion in cash and equivalents and $2.4 billion in total debt.
Technical Analysis
The technical analysis of Encompass Health Corp's stock price shows that the stock is currently trading above its 50-day and 200-day moving averages. The stock has been in a bullish trend since early 2023, and it is currently testing its 52-week high.
Short Term Outlook
The short-term outlook for Encompass Health Corp is positive. The company is expected to continue to benefit from the growing demand for post-acute healthcare services. The company's strong financial position and its recent acquisition of Kindred Healthcare will also help to drive growth in the future.
Long Term Outlook
The long-term outlook for Encompass Health Corp is also positive. The company is expected to continue to grow its market share in the post-acute healthcare market. The company's strong brand recognition and its commitment to quality care will help to drive growth in the future.
Analyst Recommendations
Analysts are bullish on Encompass Health Corp. The consensus analyst rating is "Buy", and the average analyst target price is $100.91.
